---
$id: https://graph.org.ai/products/commodity/51161530
$type: Product
source: UNSPSC
code: "51161530"
title: "Amipizone"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Amipizone

**UNSPSC Code**: 51161530
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor with the molecular formula C14H16ClN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7OT95Q2G4E, chemically known as 6-(p-(2-chloropropionylamino)phenyl)-5-methyl-4,5-dihydropyridazin-3-one but generally known as amipizone, which bears US NIH Compound Identifier 68889. European Medicines Agency schedules Amipizone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05454MIG. The term AMIPIZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). AMIPIZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amipizone under HS 29339990 and SITC 51577. As of Q4 2014, AMIPIZONE remains the US FDA Preferred Term for this commodity. Amipizone bears US NLM identifiers UMLS ID C2698092 and NCI Concept Code C74345. SMILES: CLC(C(=O)NC1CCC(C2=NNC(=O)CC2C)CC1)C.

